|
⚲
|
| Keyboard |
| Dube Michael P
✚
|
|
|---|---|
| CIK # | 0002019493 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0002019493] | |
| 4 | [0002019493] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Dube Michael P | |
| Intellia Therapeutics Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Intellia Therapeutics Inc NTLA
Common Stock
|
2026-03-01 | Grant | 17,250 | $0.00 | |
|
Intellia Therapeutics Inc NTLA
Common Stock
|
2026-01-05 | Sell | 2,989 | $9.21 | 27,529 |
|
Intellia Therapeutics Inc NTLA
Common Stock
|
2025-10-01 | Sell | 1,871 | $17.38 | 32,518 |
|
Intellia Therapeutics Inc NTLA
Common Stock
|
2025-07-02 | Sell | 2,503 | $9.95 | 24,905 |
|
Intellia Therapeutics Inc NTLA
Common Stock
|
2025-03-01 | Grant | 14,000 | $0.00 | |
|
Intellia Therapeutics Inc NTLA
Common Stock
|
2025-01-03 | Sell | 1,372 | $12.18 | 16,711 |
|
Intellia Therapeutics Inc NTLA
Common Stock
|
2024-10-02 | Sell | 2,012 | $19.01 | 38,248 |
|
Intellia Therapeutics Inc NTLA
Common Stock
|
2024-07-01 | Grant | 17,801 | $0.00 |